Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization. Publication Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization. See how PopPK modelling in Chinese premature infants identifies key covariates and supports model‑based amikacin…CertaraDecember 6, 2025
PK Report Creation with AI: From Days to Minutes On-Demand Webinar PK Report Creation with AI: From Days to Minutes AI PK Reports, a component of Phoenix Cloud, turns the protocol, data tables and figures…CertaraDecember 4, 2025
Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats Publication Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats Learn how phospholipid‑based formulations significantly increased lutein and zeaxanthin exposure versus MCT oil, analysed using…CertaraDecember 2, 2025
Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation Publication Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation Find out how PopPK modelling shows major gestational changes in lamotrigine clearance and supports precise…CertaraNovember 20, 2025
Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data. Publication Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data. Explore how Phoenix NLME simulations highlight variability in perioperative ibrutinib exposure and the impact of…CertaraNovember 20, 2025
ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™ Blog ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™ At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…CertaraNovember 13, 2025
Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® On-Demand Webinar Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…CertaraNovember 13, 2025
Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk Publication Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk Discover how PBPK and clinical data show low infant exposure to doravirine during breastfeeding, supported…CertaraNovember 6, 2025
Certara Automates Scientific Workflows with Phoenix® Cloud Press Release Certara Automates Scientific Workflows with Phoenix® Cloud Certara has released TFL studio, a module in its cloud-native PK/PD software, Phoenix Cloud, to…CertaraNovember 4, 2025
Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers Publication Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers See how subcutaneous rhSOD shows sustained exposure and favourable safety compared with IV dosing, analysed…CertaraOctober 18, 2025